Combined Intratympanic and Systemic Use of Steroids for Idiopathic Sudden Sensorineural Hearing Loss
Otology & Neurotology, 06/10/2011
Arslan N et al. – Both the mean and the median PTA gains were statistically significantly different between systemic corticosteroid therapy(SCT) and combined treatment(CT) groups. According to improved hearing results (more than 10 dB gain), there was statistically significant difference between SCT and CT groups. None of the patients had an important complication. The results of this study suggest that adding intratympanic methylprednisolone to systemic therapy increases the probability of hearing recovery in ISSHL patients.